back to article Breast cancer screening AI app OK'd by watchdog

An AI application that aids early stage breast cancer screening has been approved by the US Food and Drug Administration for commercialization, software developer MedCognetics announced this week. MedCognetics, based in Texas, has built a cloud-based software-as-a-service system for radiologists that analyzes mammograms. The …

POST COMMENT House rules

Not a member of The Register? Create a new account here.

  • Enter your comment

  • Add an icon

Anonymous cowards cannot choose their icon

Other stories you might like